Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Drug Alcohol Depend. 2012 Sep 27;129(1-2):25–32. doi: 10.1016/j.drugalcdep.2012.09.005

Table 3.

MNLFA Estimated Symptom Psychometric Properties*

Symptom Observed Probability of Endorsement Intercept Loading Estimated Probability of Endorsement for ND severity score =1
NESARC SECASP
Withdrawalb .18 .49 −10.78 5.52 .01
Withdrawal symptoms uncomfortable/upsetting/interfere w/work, social activitiesb .11 .47 −8.80 4.42 .01
Smoke to keep from feeling withdrawal symptomsb .18 .51 −8.25 4.19 .02
Smoke despite promising yourself not to NA .60 −2.61 LF
−2.33WF
−3.88 DF
1.78 .30LF
.37WF
.11DF
Use more frequently than intended b .31 .58 −3.02 1.92 .25
Tried to cut down/quit but could not .44 .47 −3.48N
−5.30 S
2.57 .29 N
.06 S
Chain smoking b .32 .37 −4.15LQ
−3.37MQ
−2.58HQ
1.73 .08 LQ
.16 MQ
.30 HQ
Give up activities to use b .07 .17 −5.03 1.59 .04
Health problem .45 .44 −1.88N,LQ
−1.22 N,MQ
−0.54 N,HQ
−3.00N,LQ
−2.33 N,MQ
−1.65 N, HQ
0.87LF
1.48WF
1.84DF
.27 N,LQ,LF .11 S,LQ,LF
.41 N,MQ,LF 19,S,MQ,LF
.58 N,HQ,LF .31,SHQ,LF
.49 N,LQ,DF .24S,LQ,DF
.65 N,MQ,DF.38S,MQ,DF
.79 N,HQ,DF .55S,HQ,DF
Emotional problem b .14 .35 −5.52 2.39 .04
Strong desire to smoke NA .41 −6.97 3.21 .02
Need to smoke more to feel satisfied b .14 .59 −1.29 1.37 .52
Need to smoke more to feel effects NA .72 −3.48 LF
−7.00WF
−6.05 DF
2.04 .19 LF
.02 WF
.01 DF
Increased use by 50% or more .15 NA −4.25 1.69 .07

Note. In the mixed model parameterization, higher (more positive) intercepts reflect lower severity, and higher loadings reflect greater discrimination.

NA = not measured. Superscripts indicate parameter estimates for study (N=NESARC; S=SECASP), smoking quantity (LQ=low quantity (−1 sd), MQ=mean quantity, HQ=high quantity (+1 sd)), and smoking frequency (LF=less than weekly smoking, WF=weekly, DF=daily smoking).

*

Using the Benjamini-Hochberg correction for multiple significance testing.

a

Low endorsement rate prohibited tests for DIF.

b

Significantly different (p<.05) symptom prevalence rates between studies based on bivariate chi-square tests.